Popular Drug Delivery News and Current Events

Popular Drug Delivery News and Current Events, Drug Delivery News Articles.
Sort By: Most Relevant | Most Recent
Page 1 of 25 | 1000 Results
Targeted delivery of highly toxic anti-cancer drug to brain tumors
University of Houston biomedical researcher Sheeren Majd is reporting the development and testing of a new nano-carrier as a potential treatment to deliver highly toxic medicine to glioblastomas, the most common and aggressive form of primary brain tumors. (2021-02-23)

Don't treat e-cigarettes like cigarettes
Assuming e-cigarettes are equal to cigarettes could lead to misguided research and policy initiatives, reports a new Northwestern Medicine commentary, published Friday, Sept. 28, in the journal Nicotine & Tobacco Research. The commentary distills articles and published studies that compare e-cigarettes to cigarettes and supports the importance of investigating e-cigarettes as a unique nicotine delivery system. It was published less than a month after the U.S. Food and Drug Administration declared youth vaping an epidemic. (2018-10-01)

Tiny soft robot with multilegs paves way for drugs delivery in human body
A novel tiny, soft robot with caterpillar-like legs capable of carrying heavy loads and adaptable to adverse environment was developed from a research led by City University of Hong Kong (CityU). This mini delivery-robot could pave way for medical technology advancement such as drugs delivery in human body. (2018-09-26)

New treatment offers potentially promising results for the possibility of slowing, stopping, or even reversing Parkinson's disease
A pioneering clinical trials program that delivered an experimental treatment directly to the brain offers hope that it may be possible to restore the cells damaged in Parkinson's disease. The study investigated whether boosting the levels of a naturally-occurring growth factor, Glial Cell Line Derived Neurotrophic Factor (GDNF), can regenerate dying dopamine brain cells in patients with Parkinson's and reverse their condition, something no existing treatment can do. (2019-02-27)

Ingestible capsule can be controlled wirelessly
MIT researchers have designed an ingestible capsule that can be controlled using Bluetooth wireless technology. Their capsule, which can be customized to deliver drugs, sense environmental conditions, or a combination of those functions, can reside in the stomach for at least a month, transmitting information and responding to instructions from a user's smartphone. (2018-12-13)

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications. (2020-10-22)

Novel technology for anticancer drug delivery on demand
With the goal of minimizing the side effects of chemotherapy on healthy tissues, IBS scientists have developed novel nanocontainers able to deliver anticancer drugs at precise timing and location. They combines uniquely designed molecules and light-dependent drug release, which may provide a new platform to enhance the effect of anticancer therapeutics. (2018-03-09)

Breastfeeding lowers risk of type 2 diabetes following gestational diabetes
Women with gestational diabetes who consistently and continuously breastfeed from the time of giving birth are half as likely to develop type 2 diabetes within two years after delivery, according to a study from Kaiser Permanente published today in Annals of Internal Medicine. (2015-11-23)

A better way to predict diabetes
An international team of researchers has discovered a simple, accurate new way to predict which women with gestational diabetes will develop type 2 diabetes after delivery. The discovery would allow health care providers to identify women at greatest risk and help motivate women to make early lifestyle changes and follow other strategies that could prevent them from developing the disease later in life. (2016-06-23)

OptiNose presents data on highly effective migraine treatment
OptiNose AS will present new Phase II data at the American Headache Society meeting in Boston on June 28. The Phase II clinical trial studied the safety and efficacy of sumatriptan, a migraine drug, when delivered to the nose by the OptiNose powder delivery device. The OptiNose and sumatriptan combination produced efficacy results comparable to previously published results on sumatriptan injections, the fastest (and also most painful) migraine treatment currently available. (2008-06-28)

Drug safety for penguins
Researchers from the University of Liverpool have determined the most effective drug dose to help penguins in managed care fight off disease. (2017-08-04)

Hitgen and Cancer Research UK's Manchester Institute enter license agreement in lung cancer
Cancer Research UK, Cancer Research Technology (CRT), the charity's commercial arm, and HitGen Ltd, a privately held biotech company focused on early drug discovery, announced today that they have entered into a licence agreement to develop a novel class of drugs against lung cancer. (2017-02-27)

Preclinical study of therapeutic strategy for Lafora disease shows promise
A team of scientists have designed and tested in mice a novel and promising therapeutic strategy for treating Lafora Disease (LD), a fatal form of childhood epilepsy. This new type of drug is a first-in-class therapy for LD and an example of precision medicine that has potential for treating other types of aggregate-based neurological diseases. (2019-07-25)

'Chemsex' needs to become a public health priority
Chemsex -- sex under the influence of illegal drugs -- needs to become a public health priority, argue experts in The BMJ this week. (2015-11-03)

Nanoparticles deliver anticancer cluster bombs
Scientists have devised a triple-stage 'cluster bomb' system for delivering the chemotherapy drug cisplatin, via tiny nanoparticles designed to break up when they reach a tumor. (2016-03-29)

HKBU Chinese medicine scholars develop HKBU Chinese medicine scholars develop
Chinese Medicine scholars at Hong Kong Baptist University (HKBU) have succeeded in developing a novel targeted delivery system for CRISPR/Cas9 to achieve therapeutic genome editing of VEGFA in osteosarcoma (OS). (2017-11-10)

One in 10 people have traces of cocaine or heroin on their fingerprints
Scientists have found that drugs are now so prevalent that 13 percent of those taking part in a test were found to have traces of class A drugs on their fingerprints -- despite never using them. (2018-03-22)

Critical heart drug too pricey for some Medicare patients
An effective drug to treat chronic heart failure may cost too much for senior citizens with a standard Medicare Part D drug plan, said a study co-authored by a John A. Burns School of Medicine researcher at the University of Hawaii at Manoa. The therapy is a combination of sacubitril/valsartan called Entresto®. Researchers found that, even with insurance, the cost to Medicare patients may be more than $1,600 a year. (2019-07-22)

Manganese dioxide shows potential in micromotors
Manganese dioxide could make the preparation of micromotors increasingly cost-effective, opening up new avenues for their use, according to a new study from the University of Eastern Finland. (2017-11-14)

Precise technique tracks dopamine in the brain
MIT researchers have devised a way to measure dopamine in the brain much more precisely than previously possible, which should allow scientists to gain insight into dopamine's roles in learning, memory, and emotion. (2017-03-03)

Extracellular vesicles could be personalized drug delivery vehicles
Creating enough nanovesicles to inexpensively serve as a drug delivery system may be as simple as putting the cells through a sieve, according to an international team of researchers who used mouse autologous -- their own -- immune cells to create large amounts of fillable nanovesicles to deliver drugs to tumors in mice. (2018-03-12)

Report outlines priorities to improve the lives of cancer survivors and caregivers
A new report from the American Cancer Society creates a set of critical priorities for care delivery, research, education, and policy to equitably improve survivor outcomes and support caregivers. (2018-10-30)

Researchers develop breakthrough technique to combat cancer drug resistance
The ability for cancer cells to develop resistance to chemotherapy drugs -- known as multi-drug resistance -- remains a leading cause for tumor recurrence and cancer metastasis, but recent findings offer hope that oncologists could one day direct cancer cells to 'turn off' their resistance capabilities. (2018-02-08)

New patch aims to turn energy-storing fats into energy-burning fats
A new approach to reducing bulging tummy fats has shown promise in laboratory trials. It combines a new way to deliver drugs, via a micro-needle patch, with drugs that are known to turn energy-storing white fat into energy-burning brown fat. (2017-12-28)

Researchers identify new drugs that could help prevent hearing loss
Researchers from St. Jude Children's Research Hospital have discovered that inhibiting an enzyme called cyclin-dependent kinase 2 (CDK2) protects mice and rats from noise- or drug-induced hearing loss. The study, which will be published March 7 in the Journal of Experimental Medicine, suggests that CDK2 inhibitors prevent the death of inner ear cells, which has the potential to save the hearing of millions of people around the world. (2018-03-07)

Using social media big data to combat prescription drug crisis
Researchers conducted a critical review of existing literature to determine whether social media big data can be used to understand communication and behavioral patterns related to prescription drug abuse. Their study found that with proper research methods and attention to privacy and ethical issues, social media big data can reveal important information concerning drug abuse, such as user-reported side effects, drug cravings, emotional states, and risky behaviors. (2017-11-16)

A unique amino acid for brain cancer therapy
Researchers discover potential application of amino acid taurine in photodynamic therapy for brain cancer. (2017-06-23)

Radiation therapy, macrophages improve efficacy of nanoparticle-delivered cancer therapy
Massachusetts General Hospital investigators report finding finding how appropriately timed radiation therapy can significantly improve the delivery of cancer nanomedicines by attracting macrophages to tumor blood vessels, which results in a transient 'burst' of nanoencapsulated drugs from capillaries into the tumor. (2017-05-31)

Bacterial outer membrane vesicles: An emerging tool in vaccine development
Outer membrane vesicles, biological nanoparticles shed during normal growth by bacteria, have seen significant recent advances in engineering and are thus finding new utility as therapeutic and drug delivery agents. One specific research focus explored recently in the literature is the use of bacterial vesicles as adjuvants in vaccine formulations. (2017-09-26)

Nanozymes -- efficient antidote against pesticides
Members of the Faculty of Chemistry of the Lomonosov Moscow State University have developed novel nanosized agents -- nanozymes, which could be used as efficient protective and antidote modalities against the impact of neurotoxic organophosphorous compounds: pesticides and chemical warfare agents. (2017-03-07)

New technology: Edible QR code can be the medicine of the future
Researchers at the University of Copenhagen have developed a new method for the production of medicine. They print medical drugs in QR coded patterns onto an edible material. The production can be tailored to fit each patient and has the potential to protect against wrong medication and fake medicine according to the researchers. (2018-02-02)

Tumor-dwelling immune cells thwart cancer immunotherapy
Researchers have caught tumor-associated immune cells called macrophages in the act of stealing checkpoint inhibitor antibodies away from their intended T cell targets, and blocking this thievery led to improved therapeutic responses in tumor-bearing mice. (2017-05-10)

Are women really under-represented in clinical trials?
Several studies have reported a lack of gender diversity in clinical trials, with trials including mostly adult males; however, a recent review of publicly available registration data of clinical trials at the US Food and Drug Administration for the most frequently prescribed drug classes found no evidence of any systemic significant under-representation of women. The findings are published in the British Journal of Clinical Pharmacology. (2018-01-11)

Study casts doubt on ketamine nasal sprays for depression
Researchers from UNSW Sydney and the Black Dog Institute have questioned the efficacy and safety of intranasal ketamine for depression, with their pilot trial stopped early due to poor side effects in patients. (2018-03-16)

Development of a novel carbon nanomaterial 'pot'
A novel, pot-shaped, carbon nanomaterial developed by researchers from Kumamoto University, Japan is several times deeper than any hollow carbon nanostructure previously produced. This unique characteristic enables the material to gradually release substances contained within and is expected to be beneficial in applications such as drug delivery systems. (2016-08-04)

Mothers of children born with NAS are more likely to experience mental health problems
Women with a history of substance use disorders (SUD) have a high incidence of coexisting psychiatric and mood disorders as well as difficulty managing adversity. These characteristics may affect the ability of a pregnant woman with a history of SUD to cope with an infant with neonatal abstinence syndrome (NAS), particularly one with a protracted neonatal intensive care unit (NICU) course, exacerbating symptoms of mental health disorders. (2018-05-05)

In India, training informal health-care providers improved quality of care
Training informal health-care providers in India improved the quality of health care they offered to patients in rural regions, a new study reports. (2016-10-06)

Antibacterial combination could fight drug-resistant tuberculosis
Pairing the antibiotic ceftazidime with the enzyme inhibitor avibactam may be an effective treatment for drug-resistant tuberculosis, a new study reports. This antibacterial drug combination -- already in clinical use for Gram-negative bacterial infections -- could aid in stemming the growing global drug-resistant tuberculosis crisis. (2017-08-30)

Position statement: Avoid using medical marijuana to treat sleep apnea
Medical cannabis and synthetic marijuana extracts should not be used for the treatment of obstructive sleep apnea, according to a position statement from the American Academy of Sleep Medicine (AASM). (2018-04-16)

Novel approach to making therapeutic proteins at point of care
A novel approach to making therapeutic proteins allows medicine to be developed in a suitcase-size system. (2018-07-10)

Page 1 of 25 | 1000 Results
   First   Previous   Next      Last   
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.